Strong experimental evidence confirms that HDL directly alleviates atherosclerosis. HDL
particles display diverse atheroprotective functions in reverse cholesterol transport (RCT) …

The contemporary pathophysiological model of non-alcoholic fatty liver disease (NAFLD)
comprises multiple parallel pathways with a dynamic cross talk that cumulate in steatosis …

High‐density lipoprotein cholesterol (HDL) is the major promoter of reverse cholesterol
transport and efflux of excess cellular cholesterol. The functions of HDL, such as cholesterol …

Background Non‐alcoholic fatty liver disease (NAFLD) has become the most common liver
disease in children and adolescents. The optimal dietary strategy to improve hepatic …

Paraoxonase 1 (PON1) is a high density lipoprotein (HDL)-associated enzyme displaying
esterase and lactonase activity. PON1 hydrolyzes several organophosphorus (OP) …

To assess the effects of anti-TNF-α antibody (infliximab) in experimental steatohepatitis
induced by methionine-and choline-deficient (MCD) diet. The study included thirty rats. One …

The ability of Cichorium intybus root extract (chicory extract) to protect against carbon
tetrachloride (CCl4)-induced oxidative stress and hepatotoxicity was evaluated in male rats …

Abstract Background Paraoxonase-1 (PON1) is an antioxidant enzyme synthesized by the
liver. It protects against liver impairment and attenuates the production of the pro …

Non‐alcoholic fatty liver disease (NAFLD) has been known as the hepatic feature of
metabolic syndrome. Extra fat depots, especially in visceral areas, develop insulin …

The endothelium is the primary target for biochemical or mechanical injuries caused by the
putative risk factors of atherosclerosis. Endothelial dysfunction represents the ultimate link …